Process for production of improved nutritional products containing milk protein and milk saccharides, and products obtained by the process
US-2019320672-A1 · Oct 24, 2019 · US
US11312741B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11312741-B2 |
| Application number | US-201716094508-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 19, 2017 |
| Priority date | Apr 19, 2016 |
| Publication date | Apr 26, 2022 |
| Grant date | Apr 26, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a method for obtaining an N-acetylglucosamine containing neutral oligosaccharide from a fermentation broth, wherein said oligosaccharide is produced by culturing a genetically modified microorganism capable of producing said oligosaccharide from an internalized carbohydrate precursor, comprising the steps of: i) ultrafiltration (UF), preferably to separate biomass from the broth, ii) nanofiltration (NF), preferably to concentrate said oligosaccharide in the broth and/or reduce an inorganic salt content of the broth, and iii) treating the broth with an ion exchange resin, preferably to remove charged materials, and/or subjecting the broth to chromatography, preferably to remove hydrophobic impurities.
Opening claim text (preview).
The invention claimed is: 1. A method for separating lacto-N-triose II, lacto-N-tetraose, or lacto-n-neotetraose from dissolved inorganic and organic salts, acids and bases in an aqueous medium from a fermentation or enzymatic process, comprising the ordered steps of: applying ultrafiltration to said aqueous medium to form an ultrafiltration permeate; applying nanofiltration to the ultrafiltration permeate to form a nanofiltrate retentate; treating the nanofiltration retentate with a strong cation exchange resin in H + -form and then immediately with a weak anion exchange resin in free base form to form a low conductive solution of lacto-N-triose II, lacto-N-tetraose, or lacto-n-neotetraose, wherein the low conductive solution has a conductivity one to two orders of magnitude lower than the conductivity of said aqueous medium. 2. The method according to claim 1 which does not comprise electrodialysis. 3. The method according to claim 1 , wherein the lacto-N-triose II, lacto-N-tetraose, or lacto-n-neotetraose is produced by culturing a genetically modified microorganism capable of producing said oligosaccharide from an internalized lactose. 4. The method according claim 3 , wherein the genetically modified microorganism is an E. coli of LacY + phenotype. 5. The method according to claim 4 , wherein the E. coli comprises a recombinant β1,3-N-acetylglucosaminyl transferase. 6. The method according to claim 1 , wherein the low conductive solution has a conductivity below 200 μS/cm. 7. The method according to claim 1 , wherein the low conductive solution has a conductivity below 50 μS/cm. 8. The method according to claim 1 , wherein the low conductive solution has a Brix of about 6-12.
N-glycosides · CPC title
in the weakly basic form · CPC title
Nanofiltration · CPC title
Anion-exchange · CPC title
N-Acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase (2.4.1.149) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.